Arotinolol

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Arotinolol
Arotinolol.svg
Systematic (IUPAC) name
(RS)-5-(2-{[3-(tert-butylamino)-2-hydroxypropyl]sulfanyl}- 1,3-thiazol-4-yl)thiophene-2-carboxamide
Clinical data
AHFS/Drugs.com International Drug Names
Legal status
  • Prescription only
Routes Oral
Pharmacokinetic data
Bioavailability 2h
Half-life 10h
Identifiers
CAS number 41287-43-8 N
ATC code None
PubChem CID 2239
ChemSpider 2152 YesY
UNII 394E3P3B99 YesY
KEGG D07465 YesY
ChEMBL CHEMBL93298 YesY
Chemical data
Formula C15H21N3O2S3 
Mol. mass 371.54 g/mol
 N (what is this?)  (verify)

Arotinolol (INN, marketed under the tradename Almarl) is a medication in the class of mixed alpha/beta blockers.[1] A 1979 publication suggests arotinolol as having first been described in the scientific literature by Sumitomo Chemical as "β-adrenergic blocking, antiarrhythmic compound S-596".[2]

Uses[edit]

It is used in the treatment of high blood pressure.[3]

It has been proposed for use in treatment of essential tremor.[4]

Recommended dosage 10 - 30 mg

References[edit]

  1. ^ Zhao, Jin; Golozoubova, Valeria; Cannon, Barbara; Nedergaard, Jan (July 2001). "Arotinolol is a weak partial agonist on beta 3-adrenergic receptors in brown adipocytes". Can J Physiol Pharmacol 79 (7): 585–593. doi:10.1139/cjpp-79-7-585. PMID 11478592. Closed access
  2. ^ Hara, Youichi; Sato, Etsuro; Miyagishi, Akira; Aono, Shunzi; Nakatani, Hiroshi (1979). "新しいβ-受容体遮断薬,dl-2-(3'-t-Butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)-thiazole hydrochloride (S-596) の薬理作用" [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole hydrochloride (S-596), a new β-adrenergic blocking agent]. Folia Pharmacologica Japonica (in Japanese (English abstract)): 707–720. doi:10.1254/fpj.75.707. ISSN 1347-8397. open access publication - free to read
  3. ^ Wu, Haiying; Zhang, Yuqing; Huang, Jianfeng; Zhang, Yuhui; Liu, Guozhang; Sun, Ningling; Yu, Zhenqui; Zhou, Yanrong (September 2001). "Clinical trial of arotinolol in the treatment of hypertension: dippers vs. non-dippers" (PDF). Hypertension Research 24 (5): 605–10. doi:10.1291/hypres.24.605. ISSN 1348-4214. PMID 11675958. open access publication - free to read
  4. ^ Lee, Kwang-Soo; Kim, Joong-Seok; Kim, Jae-Woo; Lee, Won-Yong; Jeon, Beum-Seok; Kim, Dongjae (August 2003). "A multicenter randomized crossover multiple-dose comparison study of arotinolol and propranolol in essential tremor". Parkinsonism & Related Disorders 9 (6): 341–347. doi:10.1016/S1353-8020(03)00029-4. PMID 12853233. Closed access

External links[edit]

http://sdic.sookmyung.ac.kr/drug_monograph/view.asp?id=92